EPO and hepcidin plasma concentrations in blood donors and β‐thalassemia intermedia are not related to commercially tested plasma ERFE concentrations

por Schotten, Nienke, Laarakkers, Coby M. M., Roelofs, Rian W., Origa, Raffaella, van Kraaij, Marian G. J., Swinkels, Dorine W.
Publicado 2017

Ensuring HLA‐matched platelet support requires an ethnic diverse donor population

por Kreuger, Aukje L., Haasnoot, Geert W., Somers, Judith A.E., Tomson, Bert, van der Bon, Johanna G., van Kraaij, Marian G.J., Weller, Claudia M.
Publicado 2020

Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks

por Saadah, Nicholas H., Schipperus, Martin R., Wiersum-Osselton, Johanna C., van Kraaij, Marian G., Caram-Deelder, Camila, Beckers, Erik A.M., Leyte, Anja, Rondeel, Jan M.M., de Vooght, Karen M.K., Weerkamp, Floor, Zwaginga, Jaap Jan, van der Bom, Johanna G.
Publicado 2020

A Conceptual Framework for Optimizing Blood Matching Strategies: Balancing Patient Complications Against Total Costs Incurred

por van Sambeeck, Joost H. J., de Wit, Puck D., Luken, Jessie, Veldhuisen, Barbera, van den Hurk, Katja, van Dongen, Anne, Koopman, Maria M. W., van Kraaij, Marian G. J., van der Schoot, C. Ellen, Schonewille, Henk, de Kort, Wim L. A. M., Janssen, Mart P.
Publicado 2018